MRNA Today - Aug 13: Bank of America Sells Shares

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

MRNA Today - Aug 13: Bank of America Sells Shares

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Moderna today. So, MRNA had a pretty chill day, just barely moved up, closing at 64 bucks and change. Not a crazy jump, but hey, at least it’s not in the red!

Now, let’s get into what’s going on. The big news today? Bank of America decided to sell off a hefty chunk of Moderna shares—like, almost 400,000 of them! Yeah, that one stung a bit for the stock. When big players like that start selling, it can freak people out, and some folks hit the sell button fast. So, there was definitely some nervous energy in the air.

On the flip side, we also heard from Capital World Investors. They filed a report saying they have a 5.6% stake in Moderna. So, it’s not all doom and gloom. It shows there’s still interest from some heavy hitters. But with the Bank of America news, it kind of overshadowed that positive vibe.

And here’s something else that caught my eye. The CDC is keeping quiet about a report on COVID-19 vaccine effectiveness. That’s kind of a big deal, especially with all the chatter around vaccines and health stuff lately. Also, Moderna’s got some mRNA bird flu vaccine in late-stage testing, which could be a big step forward for them. So, they’re still in the game, just dealing with some market drama.

To wrap it up, Moderna had a slow day, mostly influenced by that big sell-off from Bank of America. But there’s still some positive movement in the background with other investors and ongoing projects. Just remember, this info is for your entertainment, not financial advice. Catch you later!

まだレビューはありません